Home/Filings/4/0001104659-15-053972
4//SEC Filing

Neos Therapeutics, Inc. 4

Accession 0001104659-15-053972

CIK 0001467652operating

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 8:31 PM ET

Size

20.3 KB

Accession

0001104659-15-053972

Insider Transaction Report

Form 4
Period: 2015-07-28
Transactions
  • Conversion

    Common Stock

    2015-07-28+35047,825 total
  • Conversion

    Series B Preferred Stock

    2015-07-288,6500 total
    Common Stock (3,604 underlying)
  • Conversion

    Common Stock

    2015-07-28+3,60429,314 total
  • Exercise of In-Money

    Preferred Stock Warrant (Right to Buy)

    2015-07-284,2000 total
    Exp: 2020-02-23Series C Preferred Stock (840 underlying)
  • Conversion

    Series B-1 Preferred Stock

    2015-07-2822,7000 total
    Common Stock (9,458 underlying)
  • Conversion

    Common Stock

    2015-07-28+9,45838,772 total
  • Conversion

    Series C Preferred Stock

    2015-07-288400 total
    Common Stock (350 underlying)
  • Conversion

    Common Stock

    2015-07-28+8,70347,475 total
  • Conversion

    Series C Preferred Stock

    2015-07-2820,8900 total
    Common Stock (8,703 underlying)
Footnotes (2)
  • [F1]Each share of the Issuer's Series B preferred stock, Series B-1 preferred stock and Series C preferred stock was automatically converted on a 2.4-for-1 basis into common stock immediately prior to the closing of the Issuer's initial public offering. The shares of Series B preferred stock, Series B-1 preferred stock and Series C preferred stock had no expiration date.
  • [F2]The preferred stock warrant was automatically exercised immediately prior to the closing of the Issuer's initial public offering for such number of shares issuable pursuant to a cashless net exercise provision pursuant to which the holder received a net number of shares of Series C preferred stock based on the fair market value of such stock at the time of exercise, after deducting the aggregate exercise price (the "Cashless Exercise Provision"). The shares of Series C preferred stock have no expiration date.

Documents

1 file

Issuer

Neos Therapeutics, Inc.

CIK 0001467652

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001467652

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 8:31 PM ET
Size
20.3 KB